Headache specialist · Memorial Sloan Kettering · United States (US) · Neurology
Data minimisation
Cadence target for Tier 3: 1 per year (assumption)
2 of 1 expected engagements
All engagements including drafts, newest first
| Date | Type | Format | MSL | Product | Topics | Insights | Flags | Status | |
|---|---|---|---|---|---|---|---|---|---|
| 04 Jul 2026 | Scientific exchange | In person | Luis Ortega | Lumeva | Real-world persistenceMedication-overuse headache | 1 | — | Reviewed | ENG-0190 |
| 25 Apr 2026 | Scientific exchange | Phone | Luis Ortega | Lumeva | Drug interactionsSwitching between CGRP agents+1 | 0 | — | Reviewed | ENG-0176 |
| 23 Jan 2026 | Congress meeting | In person | Luis Ortega | Lumeva | Real-world persistence | 1 | — | Reviewed | ENG-0175 |
04 Jul 2026
Real-world persistence, Medication-overuse headache
25 Apr 2026
Drug interactions, Switching between CGRP agents, Chronic migraine data
23 Jan 2026
Real-world persistence
Memorial Sloan Kettering
Oncology pharmacist
Thoracic medical oncologist
Thoracic medical oncologist
Thoracic medical oncologist
Academic nephrologist
Allergist